Fund managers are buying these ASX shares

Fund managers have been loading up on these ASX shares…

| More on:
Image of fund managers on laptops with share price chart overlaid

Image source: Getty Images

I like to keep an eye on substantial shareholder notices. This is because these notices give you an idea of which shares large investors, asset managers, and investment funds are buying or selling.

Two notices that have caught my eye are summarised below. Here’s what this fund manager has been buying:

Bapcor Ltd (ASX: BAP)

According to a change of interests of substantial holder notice, AustralianSuper has been increasing its stake in this auto parts retailer again.

The notice reveals that the super fund has added approximately 3.5 million shares to its holding over the last three months. As a result, AustralianSuper now owns a total of 27,645,723 Bapcor shares, which is the equivalent of an 8.15% stake.

AustralianSuper was purchasing shares as recently as 25 August when it picked up 279,699 shares at an average of $7.48 per share. This is higher than the latest Bapcor share price of $7.23, giving investors an opportunity to buy in at a cheaper price than what AustralianSuper paid.

The team at Macquarie certainly see this share price weakness as a buying opportunity. Last week the broker put an outperform rating and $8.55 price target on Bapcor’s shares.

Hipages Group Holdings Ltd (ASX: HPG)

Another change of interests of substantial holder notice reveals that Challenger Ltd (ASX: CGF) has been buying more of this online tradie marketplace provider’s shares.

According to the notice, Challenger has picked up ~1.3 million shares over the last few months. This has brought its holding to a total of 7,909,443 shares, which equates to a 6.08% stake.

The fund manager’s last purchase came on 31 August when it paid $155,375 for 42,649 shares. This represents an average of $3.64 per share, which is broadly in line with where the Hipages share price trades today.

The good news for Challenger is that the team at Goldman Sachs see plenty of upside from here. They recently retained their buy rating and lifted their price target on Hipages’ shares to $4.35.

Should you invest $1,000 in Hipages right now?

Before you consider Hipages, you'll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Hipages wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of January 13th 2022

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Hipages Group Holdings Ltd. The Motley Fool Australia owns shares of and has recommended Bapcor and Challenger Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News